RxSight, Inc. (RXST) Stock

RxSight, Inc., a leading innovator in medical technology, specializes in the development, manufacturing, and global distribution of light adjustable intraocular lenses (LAL) designed for cataract surgery. Based in Aliso Viejo, California, the company was originally established in 1997 under the name Calhoun Vision, Inc., rebranding to RxSight, Inc. in February 2017. RxSight's flagship product, the RxSight system, represents a significant advancement in post-cataract surgery care, offering customizable solutions to enhance visual acuity.

At the core of RxSight's offerings is its proprietary RxSight light delivery device. This innovative technology allows ophthalmologists to precisely adjust the implanted LAL through targeted UV light exposure, tailored to meet each patient's specific visual needs post-surgery. By enabling these adjustments in an office-based setting, RxSight empowers healthcare professionals to optimize patient outcomes with personalized vision correction solutions.

RxSight primarily serves the global community of cataract surgeons, providing them with advanced tools to achieve superior clinical results and patient satisfaction. The company's commitment to research and development underscores its dedication to continuously improving surgical outcomes and expanding the frontiers of intraocular lens technology.

With a strong focus on innovation and patient care, RxSight remains at the forefront of the ophthalmic industry, driving advancements that enhance the quality of life for individuals undergoing cataract surgery worldwide.